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ABSTRACT 
 Coronary slow flow is a phenomenon that is found in coronary angiography.It is a 
rare case and identified by the corrected TIMI frame count. The presence of a slow flow in 
the coronary arteries is associated with life-threatening arrhythmias, sudden death, and 
acute coronary syndrome. We aim to report a coronary slow flow phenomenon present with 
non-ST-elevation acute myocardial infarction and sustained slow ventricular tachycardia in 
66-year-old male patient. Brief heparinisation and continued by oral acetosal, ticagrelor, 
bisoprolol and atorvastatin therapy successfully diminish the symptom. 
 
Keywords: coronary slow flow phenomenon;ventricular tachycardia; non-ST-elevation 
acute myocardial infarction 
 
INTISARI 
Aliran lambat koroner adalah fenomena yang ditemukan dalam pemeriksaan 
angiografi koroner. Fenomena ini jarang dijumpai dan diidentifikasi melalui jumlah frame 
TIMI terkoreksi. Munculnya fenomena aliran lambat di arteri koroner berhubungan dengan 
aritmia yang mengancam jiwa, kematian mendadak, dan sindrom koroner akut. Kami 
bermaksud melaporkan fenomena aliran lambat koroner yang bermanifes sebagai  infark 
miokard akut non-ST-elevasi dan takikardia ventrikel lambat yang menetap pada pasien pria 
berusia 66 tahun. Pemberian heparinisasi dalam waktu singkat dan dilanjutkan dengan obat 
oral asetosal, ticagrelor, bisoprolol, dan atorvastatin berhasil mengurangi gejala. 
 
INTRODUCTION 
The coronary slow flow 
phenomenon (CSFP) is an angiographic 
finding typified by delayed opacification to 
the distal vasculature in the absence of 
obstructive epicardial coronary artery 
disease (CAD).1 It is a rare phenomenon 
with the incidence around 1-7% among 
coronary angiograms.1 The CSFP patients 
were mostly young males and have risk 
factors of smoking, hypertension and 
dyslipidaemia.2 They often present with 
acute chest pain and ECG changes. An 
ischaemic origin in those with the CSFP 
suggest that T wave changes in ECG may 
be an indication of microvascular 
dysfunction.3  
The significance of CSFP in 
patients with angina is unclear and 
therefore an effective treatment is 
unknown. Recently CSFP has been found 
to be associated with increased QTc 
dispersions, which may be an 
independent risk factor for ventricular 
arrhythmias and sudden cardiac death.2 
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Here we report the CSFP in male 
patient with clinical presentation of non-
ST-elevation acute myocardial infarction 
(NSTEMI) and sustained slow ventricular 
tachycardia (VT).  
 
CASE REPORT 
A 66-year-old man came to the 
emergency unitof Dr. Sardjito Hospital, 
Yogyakarta with chief complaint of chest 
pain. Ten hours before coming to the 
emergency unit, he suffered from chest 
pain radiating to the right and left arms, 
accompanied with diaphoresis and 
abdominal dyscomfort. He tried to 
assuage the chest pain by taking analgetic 
remedy, however the pain persisted. The 
patient visited nearby hospital and was 
diagnosed as non-sustained VT. He was 
referred to the emergency unit of Dr. 
Sardjito Hospital. At the emergency unit, 
the chest pain was still presented but 
without diaphoresis, abdominal discomfort 
and shortness of breath. The patient had 
history of bronchial asthma and 
hypertension. 
On physical examination, the 
patient was fully conscious, with blood 
pressure 177/107 mmHg, pulse rate 72 
x/minute (regular), respiratory rate 20 
x/minute, and axillae temperature 36.7 . 
The JVP was 5+2 cmH2O. At chest 
examination was unremarkable. Lung and 
heart examination were also normal. 
Abdominal and extremity examination 
were normal. An ECG examination from 
district hospital showed  the sinus rhythm, 
right axis deviation and bigemini ventricle 
extrasystole (Figure 1). The QTc 
dispersion from the ECG was 120 msec 
(Figure 2).  
An ECG examination on the 
emergency room at our hospital showed a 
sinus rhythm, right axis deviation, with 
periodic slow VT (Figure 3). The 
laboratory examination results were: 
haemoglobin level 17 g/dL, haematocrit 
52.6%, platelet count 279,103 /µL, 
leukocyte count 10,6000 /µl, albumin level 
5.02 g / dL, GOT level 158 U/L,GPT level 
10 U/L, glucose level 95 mg/dL, urea 
nitrogen level 12 mg/dL, creatinine level 
1.3 mg/dL, sodium level 137 mmol/L, 
potassium level 4.62 mmol/L, chloride 
level 101 mmol/L, calcium level 2.1 
mmol/L, and magnesium level 2.28 
mmol/L. Cardiac enzyme showed 
increasing level of  CKMB (226 U/L) and 
hs-troponin I (38.455 ng/L).  
The patient was assessed with 
NSTEMI Killip I with sustained slow VT (a 
very high risk). The patient was 
administered bolus and continuous 
infusion of unfractionated heparin (UFH), 
ticagrelor 180 mg and acetosal 320 mg. 
He was performed an immediate invasive 
strategy by coronary angiography, and the 
result showed: left main (LM) was normal; 
left anterior descendent (LAD) was 
ecstatic in the proximal part and 30% 
stenosis in the middle part with slow flow; 
left circumflex artery (LCx) was 50% 
stenosis in the proximal part, thrombus in 
the distal part with slow flow; right 
coronary artery (RCA) was 30% stenosis 
in the middle part with slow flow (Figure 
4).  
No coronary intervention was 
performed to the patient. Because of high 
burden thrombus, optimal medical therapy 
with antithrombotic was decided. The 
patient was transferred to Intensive 
Cardiac Care Unit (ICCU) and received 
600 U/hour of UFH, and oral treatment of  
acetosal 80 mg q.i.d., ticagrelor 90 mg 
b.i.d., atorvastatin 40 mg q.i.d., captopril 
25 mg t.i.d. and bisoprolol 2.5 mg q.i.d.. 
The transthoracic echocardiography 
examination showedglobal LV systolic 
function (ejection fraction) was normal, i.e. 
54%, segmental wall motion abnormalities 
were present, i.e. hypokinetic basal-mid 
inferoseptalwall, inferolateral basal-mid 
wall and inferior basal-mid wall.  
 
DISCUSSION  
We report a 66-year-old man with 
coronary angiography diagnosis of CAD 
non-significant with slow flow presenting 
with NSTEMI and sustained slow VT.In 
this case, by coronary angiography it can 
be detectedthe slowdown of contrast flow 
in all coronary arteries. As one example 
wasof the LAD, the number of frames from 
osteal to distal LAD was 65 with the 
corrected TIMI frame count(CTFC) of 38.
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Figure 1.ECG examination in previous hospital showed sinus rhythm, right axis deviation, and 
bigemini pattern ventricle extrasystole. 
 
Figure 2. Twelve-Lead ECG at 50 mm/sec speed showing QT dispersion of 120 msec and QTc 
dispersion of 120 msec. 
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Figure 3. ECG examination in  Dr. Sardjito hospital showed sinus rhythm and periodic slow ventricular 
tachycardia (VT). 
 
 
 
 
 
 
 
 
 
   
 
 
 
A        B 
 
 
 
 
 
 
 
 
 
 
 
 
 
  C        D 
 
Figure 4. Coroangiography: A. Left Main (LM) : normal, B. Left Anterior Descenden (LAD) : proximal 
ectatic, 30% mid stenosis, slow flow,C. Left Circumflex artery (LCx) : 50% proximal stenosis, 
thrombus appears at distal, slow flow,D. Right Coronary Artery (RCA) : proximal ectatic, 30% mid 
stenosis, slow flow.
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Figure 5.Corrected TIMI frame count using the Gibson's method. Point A = the frame count when 
theostium of the vessel gets opacified. Point B = the frame count when the pre-specified most 
distalvessel segment gets opacified. CTFC = Corrected TIMI frame count. 1.7 is the correction 
factorused for the LAD due to its longer length.Corrected TIMI Frame Count in LAD which shows 
slow coronary flow.Number of frames from pointA to B = 65, CTFC = 65/1.7 = 38.Normal CTFC for 
LAD= 21 2 
 
Table 1.Clinical criteria for suspecting microvascular angina (MVA)2 
1. Symptoms of myocardial ischemia 
a. Effort and/or rest angina 
b. Angina equivalents (i.e. shortness of breath) 
2. Absence of obstructive CAD (<50% diameter reduction or FFR >0.80) by 
a. Coronary CTA 
b. Invasive coronary angiography 
3. Objective evidence of myocardial ischemia 
a. Ischemic ECG changes during an episode of chest pain 
b. Stress-induced chest pain and/or ischemic ECG changes in the presence or 
absence of transient/reversible abnormal myocardial perfusion and/or wall 
motion abnormality 
4. Evidence of impaired coronary microvascular function 
a. Impaired coronary flow reserve (cut-off values depending on methodology use 
between ≤2.0 and ≤2.5) 
b. Coronary microvascular spasm, defined as reproduction of symptoms, 
ischemicECG shifts but no epicardial spasm during acetylcholine testing. 
c. Abnormal coronary microvascular resistance indices (e.g. IMR >25) 
d. Coronary slow flow phenomenon, defined as TIMI frame count >25. 
 
No. of frames from point A to B = 65 
 
CTFC = 65 /1,7 = 38 
 
Normal CTFC for LAD = 21   2 
Point B 
Point A 
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The normal CTFC value was 21±2. 
It indicated that there was a slowdown in 
contrast flow of the LAD (Figure 5).  
The CSFP in coronary 
angiographic studies was initially 
described subjectively by visual judgment. 
A semi-quantitative assessment of 
coronary blood flow is the thrombolysis 
TIMI flow grade classification, which 
reflects the speed and completeness of 
the passage of the injected contrast 
through the coronary arteries.4  
This broadly used technique to 
grade coronary flow has variability in the 
visual assessment which limits the clinical 
applicability. The CTFC is an objective 
quantitative index of coronary flow and 
assists the standardization of TIMI flow 
grades and flow assessment.5It 
representsthe number of cineframes 
required for contrast to arrive at 
prespecified distal coronary artery 
landmarks.5 A CSFP is defined as a CTFC 
greater than 2 standard deviations (SD) 
from the normal published range,which is 
21±3.5.5 
The precise pathogenesis of CSFP 
is still unclear. Multifactorial involvement 
have been implicated in the pathogenesis, 
such as microvasculature functional and 
structural abnormality, endothelial 
dysfunction, chronic inflammation, occult 
coronary atherosclerosis and epicardial 
coronary artery anatomy pattern.1 Most 
importantly, CSFP was associated with 
life-threatening arrhythmias and sudden 
cardiac death, probably due to increased 
QTc dispersion.4  
The QTc dispersion is defined as 
the difference between the maximum and 
minimum QTc interval in a standard 12-
lead ECG, which indicates the dispersion 
of ventricular repolarization. Increased 
QTc dispersion has been linkedto 
increased incidence of ventricular 
arrhythmias and associated with an 
adverse prognosis in a varietyof patient 
populations.6 Most patients with the CSFP 
demonstrate the ST and T wave changes 
during an ACS presentation.3  
The strong association with T wave 
changes raises the possibility that the T 
wave may be a marker of coronary 
microvascular  dysfunction (CMD).3  
Standardization of diagnostic 
criteria for ischemic symptoms due to 
CMD is required to further investigation of 
patients presenting with angina consistent 
with microvascular angina (MVA).2 There 
isclinical criteria for suspecting MVA 
(Table 1).  
Based on the criteria, a definitive 
MVA is diagnosed if all four criteria are 
present for a diagnosis of MVA and a 
suspected MVA is diagnosed if symptoms 
of ischemia are present (criteria-1) with no 
obstructive coronary artery disease 
(criteria-2) but only (a) objective evidence 
ofmyocardialischemia (criteria-3), or (b) 
evidence of impaired coronary 
microvascular function(criteria-4) alone.2 
Based on the criteria, ourcase hada 
definitive MVA due to CMD.  
Several drugs have been tested to 
treat CSFP. Dipyridamole, a platelet 
cAMP-phosphodiesterase inhibitor, has 
been shown to increase the extracellular 
adenosine level by inhibiting its re-
uptakeby erythrocytes and vascular 
endothelium in the coronary arteries, thus 
causing coronary arterial dilation.6  
Oral dipyridamole therapy has 
been shown to normalize the flow in 
patients with CSFP.6 Other drugs such as 
statins for its pleiotropic effects on the 
vascular function, angiotensin-converting 
enzyme inhibitors for its direct modulation 
of coronary microvascular tone, α-blockers 
for its ability to decrease sympathetic 
activity and nitric oxide potentiating β-
blocker nebivolol for its effect on 
improving flow mediated dilatation of 
brachial artery and reduced chest pain.1 
In our case, the continued 
medication with oral acetylsalicylic acid, 
ticagrelor, bisoprolol and atorvastatin 
therapy successfully diminish the 
symptom. 
 
CONCLUSION 
We report a case of 66-year-old 
man with coronary angiography diagnosis 
of CAD non-significant with slow flow 
presenting with NSTEMI and sustained 
slow VT. In this rare case, he responded 
wellto an antiplatelet, β-blocker and statin 
therapy. 
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